Interestingly, the authors in this study utilized PBMCs and whole blood from healthy controls, as well as from RA patients, and demonstrated that all the jakinibs evaluated showed similar JAK1-dependent cytokine inhibitory activity. Here, JAK1 is linked to rheumatoid arthritis.